InZS AssociatesbySebastian Karl·Aug 11Biosimilar substitution in France: Tip of the iceberg for biosimilars policy in EuropeFrance’s biosimilar shift reveals how manufacturers can compete as pharmacy substitution expands across Europe.
vinay dahiya·Jun 25The Biosimilar Boom Is Here: Is Pharmacovigilance Ready?As blockbuster biologic drugs lose patent protection, biosimilars are transforming global healthcare. But while patients gain access to…
InZS AssociatesbyPrateek Yadav·Apr 14, 2024Pushing the generics button on the biosimilars contractingUnpacking alliances between biosimilar manufacturers and payers: A deep dive by ZS’s Biosimilars CoE
Dr. ADAM TABRIZ·Mar 7, 2024FDA Approves First Interchangeable Biosimilars for DenosumabA Breakthrough in Cancer Treatment
Róbert Wessman·Jun 13, 2022An ESG FrameworkOne of the most interesting trends in the business and financial sectors is the increased attention now being paid to the sustainability of…
